| Sidransky, David |
Johns Hopkins University
United States |
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma |
5R01CA265975-04 |
|
Wendy Wang, Ph.D., M.Sc. |
| Sieren, Jessica C |
University Of Iowa
United States |
Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers |
5R01CA267820-03 |
|
Nicholas Hodges, Ph.D. |
| Sigel, Keith Magnus |
Icahn School Of Medicine At Mount Sinai
United States |
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors |
4R01CA256660-05 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
| Simeone, Diane M |
University Of California, San Diego
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
5U01CA282272-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Siminski, Suzanne M. |
Frontier Sci & Technology Rsch Fdn, Inc
United States |
CASCADE Coordinating Center |
5U24CA275417-04 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Clinical Validation Center for Hepatocellular Carcinoma |
5U01CA271887-04 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States |
5U01CA230694-05 |
|
|
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
4U01CA283935-03 |
|
Sidney Fu, M.D. |
| Siskind, Leah J |
University Of Louisville
United States |
Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease |
1R01CA305985-01 |
|
Marjorie Perloff, M.D. |
| Skates, Steven J |
Massachusetts General Hospital
United States |
Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
5U01CA260758-05 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
